Journal article
Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): Rationale and protocol
Abstract
The Canadian Amiodarone Myocardial Infarction Trial (CAMIAT) is a multicenter, triple-blind, randomized, placebo-controlled trial. Eligible patients are those found on 24-hour ambulatory electrocardiographic monitoring within 6-45 days of acute myocardial infarction to have ventricular premature depolarizations (VPDs) that are frequent (> or = 10/hr) or repetitive (> or = 1 three-beat run of ventricular tachycardia). Consenting patients are …
Authors
Cairns JA; Connolly SJ; Roberts R; Gent M
Journal
The American Journal of Cardiology, Vol. 72, No. 16, pp. f87–f94
Publisher
Elsevier
Publication Date
November 1993
DOI
10.1016/0002-9149(93)90969-j
ISSN
0002-9149